End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
53.2 TWD | -0.19% | +1.14% | +6.51% |
Business Summary
Sales per Business
TWD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 1 | 100.0 % | 31 | 100.0 % | +2,270.49% |
Sales per region
TWD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Asia
100.0
%
| - | - | 31 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Li Ko Hsu
CEO | Chief Executive Officer | - | 13/18/13 |
Cheng Yue Cheng
CHM | Chairman | - | 22/10/22 |
Ju Yi Lin
DFI | Director of Finance/CFO | 58 | 01/20/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Li Chu Lo
BRD | Director/Board Member | - | 09/21/09 |
Hong Jen Chang
BRD | Director/Board Member | 68 | 01/20/01 |
Cheng Yue Cheng
CHM | Chairman | - | 22/10/22 |
Hai Yi Ma
BRD | Director/Board Member | - | 13/17/13 |
Yue Hui Su
BRD | Director/Board Member | - | 09/21/09 |
Jen Fang Li
BRD | Director/Board Member | - | 09/21/09 |
Wen Hung Huang
BRD | Director/Board Member | - | 13/17/13 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 134,142,000 | 132,800,580 ( 99.00 %) | 0 | 99.00 % |
Company contact information
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+6.51% | 222M | |
+33.14% | 709B | |
+30.77% | 595B | |
-2.05% | 367B | |
+20.12% | 334B | |
+5.32% | 289B | |
+14.77% | 239B | |
+9.13% | 211B | |
-3.97% | 203B | |
+9.09% | 171B |
- Stock Market
- Equities
- 6838 Stock
- Company Formosa Pharmaceuticals, Inc.